CXCL1 and urinary bladder cancer: In an urine-based follow-up study, Nakashima et al. confirmed these results with measuring the concentration of urinary CXCL1 in 175 patients with bladder cancer (BCa) and 30 healthy volunteers (Nakashima et al. 2015).